BIO Joins Alliance to Protect Medical Innovation
Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement:
“BIO has joined the Alliance to Protect Medical Innovation. Small company innovators are at the center of the biopharmaceutical industry, and they will be disproportionately impacted by the flawed policies often touted as the way to lower the cost of prescription drugs. Innovation and bad public policy cannot coexist. That’s an important message often neglected in the debate about health care costs, and that’s precisely the message this organization will help deliver.”